Studies in animal models of diabetes and early clinical trials in patients with type 1 diabetes demonstrate that C-peptide in replacement doses has beneficial effects on early stages of diabetes-induced functional and structural abnormalities of the peripheral nerves, autonomic nervous system, and ...
Der CPeptid-Abfall zeigt bei Diabetes mellitus Typ 1 nach einem exponentiellen spter einen stabilen VerlaufObjectives C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing it are poorly understood. We modelled CP values in T1D patients from diagnosis for ...